Drug
Neomycin Sulfate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Macular Degeneration | 202 | 133.2 | 143.8 | signal |
| 2 | Pemphigus | 134 | 84.1 | 88.5 | signal |
| 3 | Pericarditis | 134 | 62.6 | 65.8 | signal |
| 4 | Synovitis | 137 | 59.1 | 62.2 | signal |
| 5 | Vaginal Discharge | 66 | 51.1 | 52.3 | signal |
| 6 | Paraesthesia Oral | 88 | 47.6 | 49.1 | signal |
| 7 | Oral Candidiasis | 76 | 45.4 | 46.7 | signal |
| 8 | Helicobacter Infection | 56 | 42.6 | 43.5 | signal |
| 9 | Type 2 Diabetes Mellitus | 168 | 38.6 | 41.1 | signal |
| 10 | Wound | 138 | 38.5 | 40.5 | signal |
| 11 | Folliculitis | 51 | 38.3 | 39.0 | signal |
| 12 | Hypercholesterolaemia | 45 | 36.5 | 37.1 | signal |
| 13 | Contraindicated Product Administered | 128 | 32.9 | 34.5 | signal |
| 14 | Systemic Lupus Erythematosus | 150 | 32.9 | 34.7 | signal |
| 15 | Hand Deformity | 54 | 32.0 | 32.6 | signal |
| 16 | C-reactive Protein Increased | 149 | 31.8 | 33.6 | signal |
| 17 | Psoriatic Arthropathy | 150 | 28.9 | 30.5 | signal |
| 18 | Infusion Related Reaction | 244 | 28.6 | 31.4 | signal |
| 19 | Therapeutic Product Effect Decreased | 158 | 27.6 | 29.2 | signal |
| 20 | Respiratory Tract Infection | 90 | 26.9 | 27.7 | signal |
| 21 | Bursitis | 41 | 26.3 | 26.7 | signal |
| 22 | Therapeutic Product Effect Incomplete | 225 | 24.7 | 26.8 | signal |
| 23 | Coeliac Disease | 31 | 24.5 | 24.7 | signal |
| 24 | Joint Range Of Motion Decreased | 40 | 23.2 | 23.5 | signal |
| 25 | Flank Pain | 28 | 23.2 | 23.4 | signal |
| 26 | Procedural Pain | 82 | 23.0 | 23.6 | signal |
| 27 | Fibromyalgia | 69 | 22.0 | 22.5 | signal |
| 28 | Frequent Bowel Movements | 75 | 21.6 | 22.2 | signal |
| 29 | Wheezing | 164 | 21.5 | 22.8 | signal |
| 30 | Drug Hypersensitivity | 527 | 21.0 | 25.8 | signal |
| 31 | Wound Infection | 28 | 19.9 | 20.1 | signal |
| 32 | Glossodynia | 56 | 19.4 | 19.8 | signal |
| 33 | Adverse Reaction | 32 | 18.7 | 18.9 | signal |
| 34 | Ill-defined Disorder | 146 | 18.6 | 19.6 | signal |
| 35 | Oedema | 115 | 16.4 | 17.1 | signal |
| 36 | Back Injury | 23 | 16.4 | 16.6 | signal |
| 37 | Irritable Bowel Syndrome | 44 | 15.9 | 16.2 | signal |
| 38 | Sleep Disorder | 142 | 15.7 | 16.5 | signal |
| 39 | Laryngitis | 22 | 15.7 | 15.8 | signal |
| 40 | Rectal Haemorrhage | 87 | 15.6 | 16.1 | signal |
| 41 | Sciatica | 30 | 14.6 | 14.8 | signal |
| 42 | Autoimmune Disorder | 18 | 14.5 | 14.6 | signal |
| 43 | Colitis | 68 | 14.0 | 14.3 | signal |
| 44 | Treatment Failure | 148 | 13.9 | 14.7 | signal |
| 45 | Swelling | 168 | 13.9 | 14.8 | signal |
| 46 | Injection Site Reaction | 119 | 13.4 | 14.0 | signal |
| 47 | Colitis Ulcerative | 77 | 13.4 | 13.7 | signal |
| 48 | Impaired Healing | 52 | 12.2 | 12.5 | signal |
| 49 | Sleep Disorder Due To A General Medical Condition | 25 | 12.0 | 12.1 | signal |
| 50 | Red Blood Cell Sedimentation Rate Increased | 17 | 11.9 | 11.9 | signal |
| 51 | Rheumatoid Arthritis | 172 | 11.8 | 12.5 | signal |
| 52 | Dyspepsia | 143 | 11.3 | 11.8 | signal |
| 53 | Haematochezia | 79 | 11.1 | 11.4 | signal |
| 54 | Asthma | 153 | 10.6 | 11.1 | signal |
| 55 | Pulmonary Fibrosis | 26 | 10.5 | 10.6 | signal |
| 56 | Liver Injury | 32 | 10.2 | 10.3 | signal |
| 57 | Obesity | 21 | 10.2 | 10.2 | signal |
| 58 | Foot Deformity | 14 | 9.8 | 9.8 | signal |
| 59 | Lower Respiratory Tract Infection | 57 | 9.7 | 9.9 | signal |
| 60 | Hepatic Cirrhosis | 23 | 9.5 | 9.6 | signal |
| 61 | Drug-induced Liver Injury | 36 | 9.0 | 9.1 | signal |
| 62 | Blood Cholesterol Increased | 54 | 9.0 | 9.1 | signal |
| 63 | Lower Limb Fracture | 22 | 8.9 | 9.0 | signal |
| 64 | Gait Inability | 38 | 8.9 | 9.0 | signal |
| 65 | Osteoarthritis | 46 | 8.4 | 8.5 | signal |
| 66 | Intentional Product Use Issue | 95 | 8.4 | 8.6 | signal |
| 67 | Liver Function Test Increased | 22 | 8.0 | 8.0 | signal |
| 68 | Ear Pain | 20 | 8.0 | 8.0 | signal |
| 69 | Epilepsy | 31 | 7.9 | 7.9 | signal |
| 70 | Confusional State | 163 | 7.8 | 8.2 | signal |
| 71 | Prescribed Underdose | 20 | 7.8 | 7.8 | signal |
| 72 | Upper Respiratory Tract Infection | 45 | 7.5 | 7.6 | signal |
| 73 | Underdose | 71 | 7.5 | 7.7 | signal |
| 74 | Taste Disorder | 19 | 7.3 | 7.4 | signal |
| 75 | Prescribed Overdose | 18 | 7.2 | 7.2 | signal |
| 76 | Atelectasis | 9 | 7.2 | 7.2 | signal |
| 77 | Drug Intolerance | 87 | 7.0 | 7.2 | signal |
| 78 | Hepatic Enzyme Increased | 60 | 6.8 | 7.0 | signal |
| 79 | Dermatitis Contact | 10 | 6.8 | 6.8 | signal |
| 80 | Hepatitis | 22 | 6.6 | 6.7 | signal |
| 81 | Joint Dislocation | 9 | 6.6 | 6.6 | signal |
| 82 | Chest Pain | 157 | 6.5 | 6.9 | signal |
| 83 | Joint Stiffness | 22 | 6.5 | 6.5 | signal |
| 84 | Inflammation | 43 | 6.5 | 6.6 | signal |
| 85 | Stomatitis | 50 | 6.4 | 6.5 | signal |
| 86 | Night Sweats | 26 | 6.2 | 6.3 | signal |
| 87 | Blister | 45 | 6.2 | 6.3 | signal |
| 88 | Angina Pectoris | 23 | 6.2 | 6.2 | signal |
| 89 | Mobility Decreased | 57 | 6.2 | 6.3 | signal |
| 90 | Product Use Issue | 148 | 6.1 | 6.4 | signal |
| 91 | Tenderness | 8 | 5.9 | 5.9 | signal |
| 92 | Injury | 53 | 5.8 | 5.9 | signal |
| 93 | Personality Change | 7 | 5.8 | 5.8 | signal |
| 94 | Deformity | 7 | 5.8 | 5.8 | signal |
| 95 | Productive Cough | 34 | 5.6 | 5.6 | signal |
| 96 | Dry Mouth | 58 | 5.5 | 5.6 | signal |
| 97 | Ear Infection | 19 | 5.5 | 5.6 | signal |
| 98 | General Physical Health Deterioration | 82 | 5.5 | 5.7 | signal |
| 99 | Arthropathy | 39 | 5.4 | 5.5 | signal |
| 100 | Loss Of Personal Independence In Daily Activities | 33 | 5.4 | 5.4 | signal |
| 101 | Malaise | 304 | 5.3 | 5.9 | signal |
| 102 | Nodule | 9 | 5.3 | 5.3 | signal |
| 103 | Joint Swelling | 83 | 5.3 | 5.5 | signal |
| 104 | Anorexia | 9 | 5.3 | 5.3 | signal |
| 105 | Hip Arthroplasty | 10 | 5.1 | 5.1 | signal |
| 106 | Erythema | 135 | 5.1 | 5.3 | signal |
| 107 | Sinusitis | 67 | 5.0 | 5.1 | signal |
| 108 | Maternal Exposure During Pregnancy | 57 | 5.0 | 5.1 | signal |
| 109 | Dyspnoea Exertional | 24 | 4.9 | 5.0 | signal |
| 110 | Gastrooesophageal Reflux Disease | 51 | 4.9 | 5.0 | signal |
| 111 | Lung Disorder | 31 | 4.9 | 4.9 | signal |
| 112 | Pneumonia | 203 | 4.9 | 5.2 | signal |
| 113 | Ulcer | 10 | 4.8 | 4.9 | signal |
| 114 | Exposure During Pregnancy | 39 | 4.8 | 4.9 | signal |
| 115 | Pain | 383 | 4.8 | 5.4 | signal |
| 116 | Road Traffic Accident | 26 | 4.8 | 4.8 | signal |
| 117 | Product Use In Unapproved Indication | 151 | 4.8 | 5.0 | signal |
| 118 | Depressed Mood | 32 | 4.7 | 4.7 | signal |
| 119 | Weight Decreased | 168 | 4.7 | 4.9 | signal |
| 120 | Emphysema | 6 | 4.6 | 4.6 | signal |
| 121 | Cough | 165 | 4.6 | 4.8 | signal |
| 122 | Tooth Abscess | 6 | 4.5 | 4.5 | signal |
| 123 | Dyspnoea | 331 | 4.5 | 5.0 | signal |
| 124 | Discomfort | 35 | 4.5 | 4.5 | signal |
| 125 | Multi-organ Failure | 10 | 4.4 | 4.4 | signal |
| 126 | Incontinence | 6 | 4.4 | 4.4 | signal |
| 127 | Respiratory Tract Congestion | 9 | 4.4 | 4.4 | signal |
| 128 | Gastrointestinal Disorder | 50 | 4.4 | 4.4 | signal |
| 129 | Rash | 244 | 4.3 | 4.7 | signal |
| 130 | Pharyngitis | 7 | 4.3 | 4.3 | signal |
| 131 | Therapy Non-responder | 25 | 4.3 | 4.4 | signal |
| 132 | Disability | 11 | 4.3 | 4.3 | signal |
| 133 | Anosmia | 8 | 4.3 | 4.3 | signal |
| 134 | Drug Exposure During Pregnancy | 19 | 4.3 | 4.3 | signal |
| 135 | Musculoskeletal Pain | 29 | 4.2 | 4.3 | signal |
| 136 | Musculoskeletal Stiffness | 48 | 4.2 | 4.3 | signal |
| 137 | Drug Administration Error | 17 | 4.2 | 4.2 | signal |
| 138 | Bronchitis | 40 | 4.2 | 4.2 | signal |
| 139 | Pharmaceutical Product Complaint | 14 | 4.1 | 4.1 | signal |
| 140 | Feeling Jittery | 10 | 4.0 | 4.1 | signal |
| 141 | Incorrect Product Administration Duration | 10 | 3.8 | 3.8 | signal |
| 142 | Dry Throat | 5 | 3.8 | 3.8 | signal |
| 143 | Incorrect Drug Administration Duration | 14 | 3.8 | 3.8 | signal |
| 144 | Nasal Congestion | 28 | 3.7 | 3.7 | signal |
| 145 | Unintended Pregnancy | 5 | 3.7 | 3.7 | signal |
| 146 | Rhinorrhoea | 30 | 3.6 | 3.6 | signal |
| 147 | Acne | 35 | 3.5 | 3.6 | signal |
| 148 | Drug Eruption | 8 | 3.5 | 3.5 | signal |
| 149 | Menstruation Irregular | 12 | 3.5 | 3.5 | signal |
| 150 | Lip Swelling | 15 | 3.5 | 3.5 | signal |
| 151 | Lung Infection | 7 | 3.4 | 3.4 | signal |
| 152 | Nasopharyngitis | 81 | 3.4 | 3.5 | signal |
| 153 | Eye Swelling | 16 | 3.3 | 3.4 | signal |
| 154 | Knee Arthroplasty | 9 | 3.3 | 3.3 | signal |
| 155 | Hepatic Encephalopathy | 4 | 3.3 | 3.3 | signal |
| 156 | Overdose | 92 | 3.3 | 3.4 | signal |
| 157 | Intentional Drug Misuse | 9 | 3.3 | 3.3 | signal |
| 158 | Product Quality Issue | 56 | 3.2 | 3.3 | signal |
| 159 | Pain Of Skin | 11 | 3.1 | 3.2 | signal |
| 160 | Stevens-johnson Syndrome | 9 | 3.1 | 3.1 | signal |
| 161 | Adverse Drug Reaction | 34 | 2.9 | 3.0 | signal |
| 162 | Thinking Abnormal | 7 | 2.9 | 2.9 | signal |
| 163 | Impaired Work Ability | 8 | 2.9 | 2.9 | signal |
| 164 | Mental Impairment | 9 | 2.9 | 2.9 | signal |
| 165 | Alopecia | 72 | 2.8 | 2.9 | signal |
| 166 | Drug Toxicity | 5 | 2.8 | 2.8 | signal |
| 167 | Medication Error | 20 | 2.8 | 2.8 | signal |
| 168 | Aphonia | 5 | 2.8 | 2.8 | signal |
| 169 | Adverse Event | 33 | 2.8 | 2.8 | signal |
| 170 | Crying | 13 | 2.8 | 2.8 | signal |
| 171 | Skin Irritation | 16 | 2.7 | 2.7 | signal |
| 172 | Rash Generalised | 9 | 2.6 | 2.7 | signal |
| 173 | Local Swelling | 6 | 2.6 | 2.6 | signal |
| 174 | Hepatitis C | 4 | 2.5 | 2.5 | no signal |
| 175 | No Therapeutic Response | 4 | 2.5 | 2.5 | no signal |
| 176 | Muscle Spasticity | 4 | 2.5 | 2.5 | no signal |
| 177 | Application Site Irritation | 4 | 2.5 | 2.5 | no signal |
| 178 | Anaphylactic Shock | 8 | 2.4 | 2.4 | signal |
| 179 | Decreased Immune Responsiveness | 3 | 2.4 | 2.4 | no signal |
| 180 | Metrorrhagia | 5 | 2.2 | 2.2 | no signal |
| 181 | Gastric Disorder | 10 | 2.2 | 2.2 | signal |
| 182 | Diabetes Mellitus Inadequate Control | 5 | 2.2 | 2.2 | no signal |
| 183 | Fistula | 3 | 2.1 | 2.1 | no signal |
| 184 | Vaginal Haemorrhage | 11 | 2.0 | 2.0 | no signal |
| 185 | Pregnancy | 5 | 1.9 | 1.9 | no signal |
| 186 | Peritonitis | 5 | 1.9 | 1.9 | no signal |
| 187 | Skin Burning Sensation | 14 | 1.5 | 1.5 | no signal |
| 188 | Wrong Technique In Drug Usage Process | 7 | 1.5 | 1.5 | no signal |
| 189 | Drug Prescribing Error | 3 | 1.2 | 1.2 | no signal |
| 190 | Application Site Erythema | 4 | 1.2 | 1.2 | no signal |
| 191 | Foetal Exposure During Pregnancy | 12 | 1.1 | 1.1 | no signal |
| 192 | Application Site Pruritus | 3 | 1.0 | 1.0 | no signal |